How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of transvenous obliteration for gastric varices

    Closed for comments This consultation ended on at   Request commenting lead permission

    References

    1. Park JK, Saab S, Kee ST et al. (2015) Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Digestive diseases and sciences 60(6):1543-53.

    2. Paleti S, Nutalapati V, Fathallah J et al. (2020) Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Versus Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Treatment of Gastric Varices Because of Portal Hypertension: A Systematic Review and Meta-Analysis. Journal of clinical gastroenterology 54(7):655-60.

    3. Osman KT, Nayfeh T, Abdelfattah AM et al. (2022) Secondary Prophylaxis of Gastric Variceal Bleeding: A Systematic Review and Network Meta-Analysis. Liver Transplantation.

    4. Luo X, Xiang T, Wu J et al. (2021) Endoscopic Cyanoacrylate Injection Versus Balloon-Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Bleeding: A Randomized Controlled Trial. Hepatology (Baltimore, Md.) 74(4):2074-84.

    5. Jang SY, Kim GH, Park SY et al. (2012) Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study. Clinical and molecular hepatology 18(4):368-74.

    6. Naeshiro N, Aikata H, Kakizawa H et al. (2014) Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration. Journal of gastroenterology and hepatology 29(5):1035-42.

    7. Tian X, Wang Q, Zhang C et al. (2011) Modified percutaneous transhepatic variceal embolization with 2-octylcyanoacrylate for bleeding gastric varices: long-term follow-up outcomes. AJR: American journal of roentgenology 197(2):502-9.

    8. Yamamoto A, Jogo A, Kageyama K et al. (2020) Utility of Coil-Assisted Retrograde Transvenous Obliteration II (CARTO-II) for the Treatment of Gastric Varices. Cardiovascular and interventional radiology 43(4):565-71.

    9. Park JW, Yoo JJ, Kim SG et al. (2020) Change in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous Obliteration. Gut and liver 14(6):783-91.

    10. Kim YH, Kim YH, Kim CS et al. (2016) Comparison of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Using Ethanolamine Oleate (EO), BRTO Using Sodium Tetradecyl Sulfate (STS) Foam and Vascular Plug-Assisted Retrograde Transvenous Obliteration (PARTO). Cardiovascular and interventional radiology 39(6):840-6.

    11. de Franchis R, Bosch J, Garcia-Tsao G, et al. (2022) Baveno VII–Renewing consensus in portal hypertension. Journal of hepatology 76(4):959-74.

    12. Henry Z, Patel K, Patton H, and Saad W. (2021) AGA Clinical Practice Update on Management of Bleeding Gastric Varices: Expert Review. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 19(6):1098-107e1.

    13. Garcia‐Tsao G, Abraldes JG, Berzigotti A, and Bosch J. (2017) Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 65(1):310-35.

    14. Tripathi D, Stanley AJ, Hayes PC et al. (2015) U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 64(11).

    15. Fukui H, Saito H, Ueno Y et al. (2016) Evidence-based clinical practice guidelines for liver cirrhosis 2015. Journal of gastroenterology 51(7):629-50.